Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
DOI 10.1007/s10549-009-0339-8 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
PRECLINICAL STUDY |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
Sox17, the canonical Wnt antagonist, is epigenetically inactivated |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_largest0 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
by promoter methylation in human breast cancer |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest0 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
De-Yuan Fu Æ Zhi-Min Wang Æ Li-Chen Æ |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
Bei-Lan Wang Æ Zhen-Zhou Shen Æ Wei Huang Æ |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Zhi-Ming Shao |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Received: 25 September 2008/Accepted: 3 February 2009 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
© Springer Science+Business Media, LLC. 2009 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Abstract SRY-box 17 (Sox17) is a transcription factor |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
which involved in a variety of developmental processes |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
and can act as an antagonist of canonical Wnt/fl-catenin |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
signaling pathway. However, the relationship between |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Sox17 gene expression, methylation status, and fl-catenin |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
in breast cancer has not been established. Here we report |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
that the expression level of Sox17 mRNA was dramatically |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
decreased in five different breast cancer cell lines and 23 of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
31 primary breast tumor samples, which significantly cor- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
related with its methylation status. After treated with 5-aza- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
2'-deoxycytidine (5-aza-dC, a demethylation agent), the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
expression levels of Sox17 mRNA and protein were |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
obviously increased. Restored expression of Sox17 by |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
5-aza-dC treatment decreased the expression level of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
fl-catenin in breast cancer cell lines. Furthermore, small |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
interfering RNA (siRNA)-mediated knockdown of Sox17 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
in SKBR-3 and Bacp-37 cells enhanced fl-catenin expres- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
sion. In 31 paired tissue samples, a significant difference |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
between the expression level of Sox17 and fl-catenin was |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
also observed (P < 0.001). Clinically, Sox17 methylation |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
was detected in 74.3% breast tumors (84/113) and 31.9% |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
(36/113) paired normal tissues, respectively (P < 0.0001). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Sox17 methylation was also associated with tumor stage |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
De-Yuan Fu and Zhi-Min Wang have contributed equally to this work. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
D.-Y. Fu • Li-Chen • Z.-Z. Shen • Z.-M. Shao (®) |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Department of Breast Surgery, Cancer Hospital/Cancer Institute, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
Breast Cancer Institute, Fudan University, 399 Ling-Ling Road, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Shanghai 200032, China |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
e-mail: zhimingshao@yahoo.com |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
Z.-M. Wang • B.-L. Wang • W. Huang (®) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Chinese National Human Genome Center at Shanghai, 250 Bi |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Bo Road, Shanghai 201203, China |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
e-mail: huangwei@chgc.sh.cn |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
(P = 0.028) and lymph node metastasis (P = 0.013). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
These findings indicate that silencing of Sox17 due to |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
promoter hypermethylation is a frequent event and may |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
contribute to aberrant activation of Wnt signaling in breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
cancer. Sox17 may be a valuable biomarker for the study of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
breast cancer carcinogenesis and progression. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Keywords Breast cancer • Sox17 • DNA methylation • |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_header
Wnt signaling |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_header
Introduction |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Breast cancer is the second most frequent cause of cancer |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
death among women [1]. Although considerable progress |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in both the diagnosis and adjuvant therapies has been |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
made, the pathogenesis of the disease remains poorly |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
understood. In the past few years, it has been recognized |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
that the silencing of tumor related genes associated with |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
promoter hypermethylation is a common feature in human |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer and serves as an alternative mechanism for loss of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumor suppressor gene function [2–4]. Numerous genes, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
including those involved in DNA damage repair, cell cycle |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
regulation, cell adhesion, and cell signal transduction |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
[5, 6], have been found to be hypermethylated during the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
development and progression of breast cancer. The |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
hypermethylation of these genes plays important roles in |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
carcinogenesis and tumor progression of breast cancer. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17, a member of the Sox (Sry-related high mobility |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
group box) family of transcription factors, is conserved in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
many species and participates in a variety of biological |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
activities and developmental processes [7–10]. A number |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of Sox genes are amplified or upregulated in different |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumors samples and cell lines which suggested they played |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
an important role in human tumorgenesis [11]. Sox17 gene |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
has been reported to be involved in oligodendrocyte |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
development [12], vascular development [13] and forma- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tion of definitive endoderm [14, 15]. Furthermore, Sox17 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
has an important effect on the regulation of stem cell |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
function [16–18], and can act as a negative regulation |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
factor of fl-catenin/TCF transcription activity in the Wnt |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
signal transduction pathway [19–22]. Although several |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
studies have shown that Sox17 might also play a role in |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
human carcinogenesis [19, 20, 23], its potential role in |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
human breast cancer has not been clarified. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The Wnt signaling pathway is involved in many |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
developmental processes and tumorigenesis [24, 25]. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Usually, the pathway operates by stabilizing and accumu- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lating of fl-catenin in the nucleus, where it interacts with |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
TCF/LEF transcription factors, leading to activation of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
downstream target genes [26]. Although compelling evi- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dence indicates that activation of Wnt signaling plays an |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
important role in breast cancer [27, 28], the mechanism has |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
not been well understood. Recently, many Wnt pathway |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
antagonists, such as SFRPs (SFRP1, SFRP2 and SFRP5), |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
WIF-1 and Dkk-1, have been reported to be epigenetically |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
silenced in breast cancer [29–33], indicating that epigenetic |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
silencing of Wnt inhibitors might be an important mecha- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
nism underlying activating the Wnt pathway in breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Several members of the Sox gene family, such as Sox17, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Sox3, Sox7 and Sox9, are structurally related to TCF/LEFs |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and have also been implicated in repressing the activity of fl- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
catenin [34–36]. In the case of Sox17, it can cooperate with |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fl-catenin to regulate the transcription of endodermal genes |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in Xenopus embryos [22]. Depletion of Xenopus embryos of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
endogenous Sox17 protein results in the hyperactivation of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Wnt target genes [22]. Sox17 is also indispensable for the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
specification of cardiac mesoderm in embryonic stem cells |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
by inactivating the canonical Wnt pathway [18]. Further- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
more, knockdown of Sox17 resulted in the up-regulation of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the Wnt target gene, while over-expression of Sox17 led to |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the opposite result [19, 20]. In colorectal cancer (CRC), |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox 17 also has a powerful capacity to suppress fl-catenin/T- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cell factor dependent transcription activity [20]. These |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
findings indicated that Sox17 may be one of important |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
antagonists of Wnt/fl-catenin signaling in diverse develop- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mental and disease contexts. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Previous study revealed that Sox17 mRNA was almost |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
undetectable in 66 human primary tumors derived from |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
various tissues [37]. Zhang et al. thought that the down- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
regulated expression of Sox17 gene in CRC cells was due |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
to its promoter hypermethylation, and methylation-depen- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dent silencing of Sox17 could be detected in 100% of CRC |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cell lines, almost 100% CRC tissues, 80% esophageal |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer and 50% non-small cell lung cancer tissues [20]. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Moreover, restored expression of Sox17 could decrease the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
proliferation rates of colon cancer cells, suggesting a |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
potential role in tumor suppression. Recently, our analysis |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
by DNA methylation microarray demonstrated that Sox17 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was also one of most significant hypermethylated genes in |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
In this study, we performed a parallel expression and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
promoter methylation analysis in breast cancer cell lines, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumor samples to further investigate the expression profile, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation status and clinical significance of Sox17 in |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer. In addition, the correlation between Sox17 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and fl-catenin expression levels was also evaluated to |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
investigate the potential role of Sox17 in the activation of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Wnt signaling pathway in breast cancer. Our data indicate |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
that silencing of Sox17 caused by promoter hypermethy- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lation is a frequent event and may contribute to aberrant |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
activation of Wnt signaling in breast cancer. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Materials and methods |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Cell lines and 5-aza-2'-deoxycytidine treatment |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Seven breast tumor cell lines ZR-75-30, MDA-MB-231, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
MDA-MB-435s, Bacp-37, MCF-7, T47D and SK-BR-3, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were obtained from American type culture collection |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(ATCC, Manassas, VA). Cell lines ZR-75-30, Bacp-37, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MCF-7, T47D, SK-BR-3 and cell lines MDA-MB-231, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MDA-MB-435s were maintained in DMEM and Leibo- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
vitz’s L-15 medium, respectively. Both medium were |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
supplemented with 10% fetal bovine serum (GIBCO), |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in 5% CO2 humidified atmosphere. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Cells were seeded at a density of 5 x 104 cells/cm2 in a |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
six-well plate, following a 24-h incubation, fresh culture |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
medium with or without the demethylating agent 5-aza-2'- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
deoxycytidine (Sigma–Aldrich Co. Ltd.) was added to a |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
final concentration of 5 lmol/l, and incubated for another |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
48 h. 5-aza-dC (Sigma) was freshly prepared as 2 mmol/l |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
stock solution in PBS before use. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Human breast tumor and paired normal tissue |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Between April and June 2006, 113 primary breast carci- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
nomas and paired normal tissue specimens, from which |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
RNA samples were available in 31 pairs of the samples, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were obtained from Cancer Hospital of Fudan University, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Shanghai, China. Immediately after resection, specimens |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were flashly frozen in liquid nitrogen and stored at —80°C. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The remaining tissue specimens were routinely processed |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
for histopathological analyses. Pathological information, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
including histological tumor type, primary tumor size, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
axillary lymph nodal status, grade of the disease, estrogen |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and progesterone receptors status and HER2/neu expres- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sion status, was obtained. The mean age of the patients was |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Table 1 Clinical characteristics of 113 patients with and without |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Sox17 methylation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Clinical 	No.	Sox17 methylation status	Pa value |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
parameter |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Methylated,	Unmethylated, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
n = 84 (74.3%)	n = 29 (25.7%) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Age (y) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
<50	69	51 (73.9)	18 (26.1)	0.897 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
C50	44	33(75)	11 (25) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Tumor histology |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
IDC	100	75(75)	25 (25)	0.929 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
DCIS	13	9(69.2)	4(30.8) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Stage |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
0–I	29	17 (58.6)	12 (41.4)	0.028* |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
II–IV	84	68 (81.0)	16 (19.0) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Tumor grade |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
I–II	70	54 (77.1)	16 (22.9)	0.990 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
III	22	17 (77.2)	5 (22.8) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Not known	21	13 (61.9)	8 (38.1) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Lymph node status |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Negative	71	47 (66.2)	24 (33.8)	0.013* |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Positive	42	37 (88.1)	5 (11.9) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ER status	0.905 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Negative	73	54 (74.0)	19 (26.0) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Positive	40	30 (75.0)	10 (25.0) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
PR status	0.854 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Negative	64	48 (75.0)	16 (25.0) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Positive	49	36 (73.5)	13 (26.5) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
HER-2/neu status	0.356 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Negative	78	56 (71.8)	22 (28.2) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Positive	35	28 (80.0)	7(20.0) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
a P values are obtained from X2 test |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
* Statistically significant, P < 0.05 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
49.1 years old (range 26–81 years old). Detailed clinico- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
pathologic parameters were listed in Table 1. This project |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
has been approved by the Scientific and Ethical Committee |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of the Cancer Hospital of Fudan University. All patients |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
gave written informed consent permitting the use of their |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissue for research at the time specimens were |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
collected. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Gene expression analysis by RT-PCR and real-time |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
RT-PCR |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Total RNA was isolated with RNeasy Mini kit (Qiagen |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
GmbH, Hilden, Germany) and treated with DNase, accord- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ing to the manufacturer’s instructions. First-strand cDNA |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was synthesized with oligo-dT-primers (Promega, Madison, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
WI, USA). Sox17 specific primers used were 5'-AGTGAC |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
GACCAGAGCCAGAC-3' (forward) and reverse 5'-CCTT |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
AGCCCACACCATGAAA-3'. fl-catenin specific primers |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
used were 5'-GAAACGGCTTTCAGTTGAGC-3' (forward) |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
and 5'-CTGGCCATATCCACCAGAGT-3' (reverse). Glyc- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
eraldehyde-3-phosphate dehydrogenase (GAPDH) served as |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
a control for RNA integrity and was amplified using primers: |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
5'-GAAGGTGAAGGTCGGAGTC-3' (forward) and 5'- GA |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
AGATGGTGATGGGATTTC-3' (reverse). PCR thermo |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
cycling conditions used are 1 cycle at 95°C for 15 min; 38 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cycles at 94°C for 30 s, 57°C for 30 s, and 72°C for 30 s; and |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
final extension at 72°C for 7 min. Following thermocycling, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reactions were analyzed by electrophoresis on 1.5% agarose |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
gels followed by staining with ethidium bromide and directly |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
visualized under UV illumination. Real-time PCR reactions |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were carried out using the default PCR cycle on a sequence |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
detection system ABI Prism 7900 HT (Applied Biosystems), |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and amplified cDNA was detected by SYBR Green I dye |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Qiagen GmbH, Hilden, Germany). Dissociation curve |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
analyses were performed to confirm the specificity of the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
SYBR Green signals in each experiment. Data were analyzed |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
using ABI Prism 7900 SDS Software (Sequence Detection |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Systems 2.0; Applied Biosystems). Standard curves relating |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
initial template copy number to fluorescence and amplifi- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cation cycle were generated using the amplified PCR product |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
as a template, and were used to calculate mRNA copy |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
number in each sample. Ratios of the intensities of the target |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
genes and GAPDH signals were used as a relative measure of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the expression level of target genes. Primer sequences of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17, GAPDH and fl-catenin for qRT-PCR analysis are |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
same as RT-PCR. To ensure experiment accuracy, Real-time |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
PCR assays were conducted in triplicate for each sample, and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the mean value was used for calculation. For analysis of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
matched breast tumor and normal samples, the abundance of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 and fl-catenin transcript in tumor tissues was defined |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
as one and the relative transcript abundance in normal ones |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was calculated accordingly. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Small interfering RNA (siRNA) transfection |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Small interfering RNA-mediated knockdown of Sox17 or |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
fl-catenin were performed in SKBR-3 and Bacp37 cells. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 siRNAs (sc-38429), fl-catenin siRNAs (sc-29209) |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and control siRNAs (sc-44233) was obtained from Santa |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Cruz Biotechnology Inc. (Santa Cruz, CA). The siRNA |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was introduced into the cultured cells using lipofectamine |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
2000 reagent according to the manufacturer’s instructions. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
At 48 h after transfection, cells were harvested. Sox17 or |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fl-catenin mRNA and protein levels were checked by qPCR |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and western blotting analysis, respectively. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Western blotting |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Total cell lysates were extracted from SKBR-3, Bcap37, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
MDA-MB-231, MDA-MB-435s and T47D cells, and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
quantified by BCA Protein Reagent Kit (Pierce, Rockford, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
IL). Primary antibodies of Sox17 (sc-20099), fl-catenin (sc- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
7199) and GAPDH (sc-25778) were obtained from Santa |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Cruz Biotechnology Inc. (Santa Cruz, CA). Forty micro- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
grams of protein were separated by 10% SDS–PAGE and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
then transferred to nitrocellulose membranes. Following |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
blocking, membranes were hybridized with primary anti- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
body overnight at 4°C and then hybridized with IRDye |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
700-conjugated anti-rabbit IgG secondary antibody |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Rockland, Gilbertsville, PA) in the dark for 1 h at room |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
temperature. The signals were detected using the Odyssey |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Imaging System (LI-COR Bioscience, Inc.) and analyzed |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with Odyssey software. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Genomic DNA extraction and sodium bisulfite |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
modification |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Genomic DNA was isolated from cells and tissues using |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
the DNeasy Kit (Qiagen, Hilden, Germany) and stored at |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
—20°C before use. DNA was modified with EZ DNA |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Methylation-Gold KitTM (ZYMO Research Co., Orange, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
CA) according to the manufacturer’s instruction. Briefly, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
0.5 µg denatured DNA was treated with sodium bisulfite at |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
98°C for 10 min and then 64°C for 2.5 h. Samples were |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
then applied to supplied columns, subjected to column |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
washing, desulfonation and re-washing, and then DNA was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsequently eluted with 10 µl elution buffer. Generally, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
1 µl modified DNA was used in subsequent PCRs. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Bisulfite genomic sequencing |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
The genomic DNA fragment from —180 bp to +240 bp |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
(ATG, +1) of the Sox17 gene was amplified from sodium |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bisulfate modificated DNA. The primers for BGS are 5'-GT |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
TTTGGGTAYGTTGTAGATTA-3' (forward) and 5'-CTT |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
AACCCACACCATAAAAAC-3' (reverse). The following |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
thermocycling conditions were used: 1 cycle at 95°C for |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
15 min; 38 cycles at 94°C for 30 s, 58°C for 30 s, and 72°C |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
for 30 s; and final extension at 72°C for 7 min. PCR products |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were purified with the Gel Extraction kit (Bionex), cloned |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
into pMD20-T Vector (TaKaRa, Madison, WI, USA), and |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
then transformed into E. coli strain DH10B. 10–15 colonies |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were selected to confirm the presence and size of the cloned |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
insert. Five positive clones for each sample were selected and |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
amplified using the vector’s universal primers (P2, 5'-GTA |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
AAACGACGGCCAGT-3', p4, 5'-AGAGGATAACAATT |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
TCACACAGGA-3'). After purification the sequence of PCR |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
product is analyzed using ABI 3730 DNA Sequencer |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
(Applied Biosystems). The methylation percentage for each |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sample was calculated as the number of methylated CpG |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dinucleotides from the total number of CpGs analyzed in all |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
positive clones. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Methylation specific PCR (MSP) |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
The primers for the methylated sequence of Sox17 gene |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
were 5'-GGAGATTCGCGTAGTTTTCG-3' (forward) and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
5'-AACCCGACCATCACCGCG-3' (reverse). For unme- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
thylated sequence were 5'-GGAGATTTGTGTAGTTTT |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
TG-3' (forward) and 5'-AACCCAACCATCACCACA-3' |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
(reverse). Qiagen HotStarTaq DNA polymerase was used |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
for PCR. Thermocycling conditions used were one cycle at |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
95°C for 15 min; 38 cycles at 94°C for 30 s, 59°C (for M |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
primer set) or 58°C (for U primer set) for 30 s, and 72°C for |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
30 s; and final extension at 72°C for 7 min. PCR products |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were loaded 2% agarose gels followed by staining with |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ethidium bromide and directly visualized under UV illu- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mination. SssI-methylated DNA and whole-genome-ampli- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fication (WGA) DNA of normal peripheral lymphocytes |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were used as positive and negative controls, respectively. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Statistical analysis |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Differences gene expression level in cell lines or tissues |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
was tested by Mann–Whitney U test. Gene expression |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
levels of paired samples were evaluated by the non-para- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
metric Wilcoxon Signed Ranks test. After grouping the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation levels into two categories, associations were |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tested by the use of contingency tables and the calculation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of X2 test was applied for the determination of significance |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of the association. All statistical tests are two sided, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
P < 0.05 was considered to be significant. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Results |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_largest-1 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Sox17 is a candidate for aberrant gene silencing |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
in breast cancer cells |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Promoter methylation often results in silencing of the gene |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
product and can be restored by demethylating agent 5-aza- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dC. Thus, we firstly evaluated the expression of the Sox17 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in a panel of breast cancer cell lines by RT-PCR. As shown |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in Fig. 1a, the expression of Sox17 was undetectable or |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expressed at extremely low levels in five breast cell lines |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(ZR-75-30, MDA-MB-231, MDA-MB-435s, MCF-7 and |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
T-47D), in contrast, Sox17 was expressed in cell lines |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Bacp-37 and SK-BR-3 at higher level. After these cells |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were treated with the demethylating agent 5-aza-dC, the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression of Sox17 was dramatically reactivated, where |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the Sox17 previously showed none or low expression |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Fig. 1 a). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To confirm and quantify the changes of Sox17 expres- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
sion, we conducted a qRT-PCR analysis in all 5-aza-dC |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
treated cell lines. A 48 h treatment with 5-aza-dC led to |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
significantly increase of Sox17 transcripts in these cell |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
lines compared with the untreated cells. Consistent with the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
RT-PCR results, there was no significant change in Sox17 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mRNA in 5-aza-dC treated Bacp-37 and SK-BR-3 cells |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Fig. 1b). |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
We further investigated the protein expression of Sox17 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
by western blots in four selected breast cancer cell lines |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
SK-BR-3, MDA-MB-231, T-47D and MDA-MB-435s. The |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
protein level of Sox17 was consistent with its mRNA levels |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
as represented by the results of RT-PCR and qRT-PCR |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Fig. 1 c). |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Silencing of Sox17 is associated with its promoter |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
CpG island hypermethylation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The Sox17 gene is composed of two exons. Exon 1 encodes |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
the 5' untranslated region (5'VTR) of the Sox17 transcript |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and 5' coding region including the translational initiation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
codon (ATG). Exon 2 encodes 3' coding region including |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the translational stop codon (TGA) and the 3' VTR of the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 transcript. We found that the 5' end of the Sox17 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
gene is unusually CG rich, and there is a CpG island |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
encompassing its transcription start site. Because aberrant |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cytosine methylation within CpG islands encompassing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
both the 5' flanking region and the transcriptional start site |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
was commonly observed in cancer cell genomes [38, 39], |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
we then analyzed a 420 bp segment of this region |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(-180 bp to +240 bp; ATG, +1) which contains 48 CpG |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dinucleotides and meets the criteria of a CpG island |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Fig. 2). |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To analyze the methylation status in details, we carried |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
out bisulfite sequencing in all the above cell lines. Direct |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sequencing of five individual clones of each cell line |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
showed that densely methylated CpG sites were detected in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MD-MB-231, MD-MB-435s, MCF-7, ZR-75-30 and T47D |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cell lines, while<10% methylated CpG sites were found in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Bcap-37 and SK-BR-3 cell lines (Fig. 3a, b). |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To further confirm the sequencing results, we designed a |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
set of methylation specific PCR (MSP) primers in this |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
region to detect methylation status of these breast cell lines. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The results showed that Sox17 was methylated in all |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
silenced cell lines MD-MB-231, MD-MB-435s, MCF-7, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ZR-75-30 and T47D. In contrast, there was no methylation |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
detected in Sox17-expressing cell lines Bacp-37 and |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
SK-BR-3 (Fig. 3c). After treated with 5-aza-dC, the unme- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
thylated band in MCF-7 and T47D was detected (Fig. 3d). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
DNA methylation suppress Sox17 expression |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
in primary breast tumors |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To determine whether epigenetic silencing of the Sox17 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
gene also occurs in primary breast tumors, we analyzed |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 expression in 31 paired breast tumor samples |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and corresponding normal breast tissues. We observed |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Fig. 1 RT-PCR and qRT-PCR analysis of the Sox17 gene expression |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
in breast cancer cell lines a RT-PCR analysis of Sox17 mRNA |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression in seven breast cancer cell lines (MDA-MB–231, MDA- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MB–435s, Bacp-37, T47D, ZR-75-30, MCF-7 and SK-BR-3). Sox17 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
gene expression was induced in five breast cancer cell lines (MDA- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MB-231, MDA-MB-435s, MCF-7, Bacp37 and T47D) after treating |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with DNA demethylating drug 5-aza-dC (5 µmol/l) for 48 h. GAPDH |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was amplified as an internal control. DW, distilled water, “+” and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
‘‘-”denote with and without 5-aza-dC treatment, respectively; b |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 mRNA expression analysis by qRT-PCR in seven breast cell |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lines either not-treated or treated with 5 µmol/l 5-aza-dC. GAPDH |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was used to normalize gene expression levels for each cell line. The |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
representative results, conducted in triplicates, are shown as |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mean f SD. “*”Denotes statistical significance at P < 0.05 com- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
pared to 0 h values; c Western blot analysis of Sox17 protein in four |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
selected breast cancer cell lines (SK-BR-3, MDA-MB-231, T47D and |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MDA-MB-435s). GAPDH was used as a control for the different cell |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lysates. “+” and “-”denote with and without 5-aza-dC treatment, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
respectively |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
detectable Sox17 mRNA transcripts in most normal breast |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
samples compared to tumor samples. The representative |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
results of RT-PCR were shown in Fig. 4a. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
By using qRT-PCR, we found that 23 out of 31 (74.2%) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
breast tumors exhibited a reduced expression levels of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Fig. 2 Genomic architecture of the human Sox17 gene The UCSC |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
genome browser was used to search the March 2006 assembly of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
human genome database to examine the Sox17 locus. a Location of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the Sox17 gene in human chromosome 8 (ch8 q11.23); b Exon/intron |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
structure of the human Sox17 gene. Picture is the relative location of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the two coding exons, the translational start codon (ATG); c Structure |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of the 5' end of the Sox17 gene. Graph of percent guanine (G) and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
cytosine (C) nucleotides across this region, location of the 48 CpG |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Sox17 compared to the corresponding normal breast tissue |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
(relative gene expression T/N < 0.5). A significant differ- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ence between tumor tissues and the corresponding normal |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissues was observed (Wilcoxon Signed Ranks Test, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
P < 0.005, Fig. 4b). |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Subsequently, we examined Sox17 methylation status of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
this panel of matched samples using MSP. Aberrant |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation was detected in 25 of 31 (80.6%) tumors, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
which was more frequent than that in the paired normal |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tissues (9 of 31, 29.0%; P < 0.001) (Fig. 4c). In 25 cases |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of methylated tumor samples, 21 (84.0%) showed a lower |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 expression which indicated a correlation between |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
CpG island methylation and transcriptional silencing. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Furthermore, we found the expression ratio between nor- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mal tissues and tumor tissues was significantly different in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the methylated and unmethylated tumor tissues (Mann– |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Whitney U test, P = 0.0034) (Fig. 4d). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To confirm our MSP results and determine the methyl- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
ation extent of Sox17 promoter in primary breast tumors |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dinucleotides within this region, and boundaries of the CpG island |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
(shaded region). Note also exon 1 and the transcriptional start codon |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(ATG) of the Sox17 gene; d Details of the Sox17 promoter region |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sequence. The bisulfite sequencing PCR primers are presented in red, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
italics and bold. The MSP primers were highlighted in blue with |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
underline. There are 48 CpG sites in this region, and the CpG sites |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were numbered. The first letter of the transcriptional start codon |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(ATG) is counted as ?1 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
versus paired normal tissue, we performed bisulfite |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
sequencing on one selected paired samples. We observed |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
hypermethylation of the majority of the CpG dinucleotides |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(85.4% methylation) within the region of the Sox17 pro- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
moter in tumor sample, whereas only a low-level of CpG |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation (5.8%) was in paired normal tissue (Fig. 4e). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Therefore, this result further supported the notion that |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
promoter methylation of Sox17 was predominant in breast |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer samples but not in normal tissues. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 methylation in primary breast carcinomas |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
is associated with clinicopathologic parameters |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To ascertain how commonly this epigenetic event occurs in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
breast cancer and its potential clinical significance, we |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
conducted MSP analysis in additional 82 pairs of patient- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
matched breast tumor and normal tissue samples. Together |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with the previous 31 pairs of samples, Sox17 CpG islands |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
hypermethylation was detected in 84 (74.3%) tumor |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Fig. 3 Methylation status of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Sox17 gene promoter in breast |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer cell lines. a Methylation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
patterns of individual bisulfite- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sequenced clones of the Sox17 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
promoter in breast cell lines. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Five clones from each sample |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were bisulfite sequenced to |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
obtain a representative sampling |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of methylation patterns, CpG |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dinucleotides are represented in |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
squares (■ methylated |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cytosines, ❑ unmethylated |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cytosines). Names of the cell |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lines and the percentage of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
corresponding cell line are |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
indicated on the left and right |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
side, respectively; b Illustration |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of representative examples of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the chromatograms of CpG sites |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
from 16th CpG dinucleotide to |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
23rd CpG dinucleotide of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 bisulphite sequencing |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fragment; c MSP analysis of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 gene in seven breast |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer cell lines without 5-aza- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
dC treatment. The promoter |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
region of the Sox17 gene was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylated in five cell lines |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(ZR-75-30, MDA-MB-231, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
MDA-MB-435s, MCF-7 and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
T47D). Lanes labeled M and U |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
denote products amplified by |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
primers recognizing methylated |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and unmethylated sequence, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
respectively. PC, positive |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
control, NC, negative control, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
DW, distilled water; d MSP |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
analysis of the Sox17 gene in |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
four breast cancer cell lines |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Bacp-37, MCF-7, T47D and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
SK-BR-3) with 5-aza-dC |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
treatment |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Fig. 4 Correlation analysis of |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
Sox17 expression and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation in breast cancers. a |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
RT-PCR analysis of Sox17 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
mRNA expression in breast |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer samples (T) and matched |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
normal tissue (N). GAPDH was |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
amplified as an internal control; |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
b Box plot illustration for the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression of Sox17 gene in 31 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer and paired normal |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissue samples. In |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
primary breast tumors, Sox17 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression is significantly |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reduced compared to the normal |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissue (Wilcoxon Signed |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Ranks Test, P < 0.05). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Horizontal lines, group |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
medians; boxes, 25–75% |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
quartiles, range, peak and |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
minimum; c Representative |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
results of MSP analysis of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 promoter methylation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
status in 12 of 31 primary breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancers (T) and matched normal |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissue (N). U, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
unmethylated; M, methylated; d |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Correlation between Sox17 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
promoter methylation status and |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
gene expression levels by qRT- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
PCR analysis of Sox17 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression in the 31 breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancers and matching normal |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissues. Methylation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
status was analyzed by MSP. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The bar represents ratio of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 mRNA expression levels |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in normal and tumor tissue. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 expression levels |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
correlated with the methylation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
status of the gene (P = 0.0034, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Mann–Whitney U test). e |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Bisulfite sequencing analysis of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
a selected matched breast tumor |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and normal breast tissue |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(sample brc13). (1) Result of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sequence analysis of five |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
independent clones for each |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sample (■ methylated |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cytosines, ❑ unmethylated |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cytosines). (2) Illustrates |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
representative examples of the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
chromatograms of CpG sites |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
from the 14th CpG dinucleotide |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
to the 22nd CpG dinucleotide of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the Sox17 bisulfite sequencing |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fragment |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
samples and 36 (31.9%) patient-matched normal tissue |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
of all the 113 patients (P < 0.001). The relationship |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
between Sox17 methylation and various clinicopathologi- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cal parameters was shown in Table 1. A significant |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
association was found between Sox17 methylation and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumor stage (81.0% methylated in stage II–IV tumors vs. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
58.6% in stage 0–I tumors, P = 0.028). Methylation level |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was significantly lower in tumors with node-negative |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancers than that in node-positive tumors (66.2% methyl- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ated in node-negative cancer vs. 88.1% in node-positive |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumors, P = 0.013). No significant correlation was |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
observed between Sox17 methylation and other parameters |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
such as age at diagnosis, tumor histology, ER/PR status or |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
HER-2/neu status. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Down-regulation of Sox17 by methylation may |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
upregulate the expression levels of fl-catenin |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
in breast cancer |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Several studies have demonstrated that Sox17 can |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
antagonize the canonical Wnt signaling pathway by |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
interacting with fl-catenin. Here we showed that Sox17 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was down-regulated by promoter methylation in breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer cell lines and tissues. Moreover, the expression of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 could be reversed by the treatment with 5-aza-dC, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
we hypothesized that down-regulation of Sox17 may |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
have some effects on the expression of fl-catenin. We |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
therefore examined the relationship between expression |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
levels of Sox17 and fl-catenin in breast cancer cell lines. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
In contrast to Sox17, the expression level of fl-catenin |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
presented a declining trend after treated with 5-aza-dC |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
for 48 h in both mRNA and proteins levels, respectively |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Fig. 5a, b). |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
To further test our hypothesis, we performed siRNA |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
knockdowns of Sox17 or fl-catenin in two normal Sox17 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression breast cancer cell lines SKBR-3 and Bacp37. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Quantitative RT-PCR results confirmed that mRNA level |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of fl-catenin was significantly increased in cells transfected |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with Sox17 siRNAs. Western blot analysis showed that the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
fl-catenin protein was also increased after siRNA knock- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
down of Sox17 mRNA. However, the Sox17 mRNA level |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was not dramatically changed by transfected these cells |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with fl-catenin siRNAs (Fig. 5c, d, e). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Subsequently, we performed a quantitative detection of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
the expression levels of fl-catenin in 31 breast cancer |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
samples and paired normal tissues. We found a higher |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression of fl-catenin in 20 of 31 (64.5%) breast tumors |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
compared to the corresponding normal breast tissues |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(P < 0.005, Fig. 5f). The expression ratio between tumor |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
samples and normal tissues was significantly different in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the Sox17 and fl-catenin (P < 0.001, Fig. 5g). Therefore, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
our results suggested that down-regulation of Sox17 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
by methylation could lead to the increased expression |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of fl-catenin, and the down-regulation of Sox17 by meth- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
ylation may be one of mechanisms that activates Wnt/fl- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
catenin pathway in breast cancer. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Discussion |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest-1 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
In present study, we showed that Sox17 plays an important |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
role in breast cancer through a comprehensive analysis of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 in breast cancer cell lines and primary tumors. We |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
found the expression level of Sox17 was significantly |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
decreased in five of seven breast cancer cell lines and could |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
be remarkably increased by the treatment with demethy- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lating agent 5-aza-dC. These results demonstrate that |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 is transcriptionally silenced by epigenetic inactiva- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tion in the breast cancer cell lines. Furthermore, bisulfite |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sequencing and MSP detection also revealed that the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation status of the CpG islands in Sox17 promoter |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
was strongly correlated with its expression levels. Consis- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tently, in paired breast samples, we also observed a reduced |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
level of Sox17 expression in most of tumor tissues, which |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
showed a correlation between methylation and transcrip- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tional silencing. Our results clearly indicate that epigenetic |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
silencing of the Sox]7 gene is a common event in breast |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
In about 74.3% of the 113 paired breast cancer tissues, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
the Sox]7 gene was found to be hypermethylated, which is |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
distinct to normal tissues. This indicated that epigenetic |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
silencing of Sox17 is not only a frequent and cancer-spe- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cific event in human breast cancer but also it might |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
prospectively act as a marker in distinguishing malignant |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast tissues from nonmalignant samples. Although Sox17 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation was also detected in normal tissue, there was |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
much more significant difference in stage II–IV than in stage |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
0–I tumors, suggesting this epigenetic aberration is an early |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
event in breast tumor initiation and contributed to the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
acquisition of an invasive cellular phenotype during breast |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer progression. Moreover, the significant correlation |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
between Sox17 methylation and lymph node metastases |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
further supported the important role of Sox17 in breast |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer progression. A recent study has revealed that |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
hypermethylation of Sox17 can be detected in CRC, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
esophageal squamous cancers and non-small cell lung can- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cer with a highly frequency [20]. Combined with the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
findings in our study, it strongly implied that hypermethy- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lation of Sox17 may be a common phenomenon in many |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
human malignancies, and epigenetic silencing of this gene |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
may contribute to a widespread significance for tumor |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
suppression. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
The fl-catenin is a key effector in the Wnt signaling |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
pathway [40]. In breast cancer, aberrant subcellular local- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ization of fl-catenin has been frequently observed and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
associated with poor clinical outcome [28, 41–43]. Unlike |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
t Fig. 5 Correlation between Sox 17 and fl-catenin expression in breast |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
cancer cell lines and tissues. a fl-catenin mRNA expression was |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
analyzed by qRT-PCR in seven breast cell lines not-treated or treated |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
with 5 µmol/l 5-aza-dC for 48 h. The representative results, con- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ducted in triplicates, are shown as mean f SD. “*”Denotes |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
statistical significance at P < 0.05 compared to 0 h values; b Western |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
blot analysis of fl-catenin protein in four selected breast cancer cell |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
lines (SK-BR-3, MDA-MB-231, T47D and MDA-MB-435s). GAP- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
DH is shown as a control for the different cell lysates. “+” and “-”denote with and without 5-aza-dC treatment, respectively; c, d qRT- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
PCR assay was performed in Bcap-37 (c) and SKBR-3 (d) after |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
transfection of siRNAs targeting Sox17 or fl-catenin. Experiments |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
were done in triplicate, and values indicate means f SD; e Western |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
blotting of whole cell lysates extracted from SKBR-3 and Bcap-37 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cells transfected with Sox17 and fl-catenin siRNAs. GAPDH was |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
used as a control for the different cell lysates. “C”, control siRNA; |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
“S”, Sox17 siRNA; “fl”, fl-catenin siRNA; f Box plot illustration for |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
the expression of fl-catenin gene in 31 breast cancer and paired |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
normal breast tissue samples. In primary breast tumors, fl-catenin |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression is significantly higher compared to normal breast tissue |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(Wilcoxon Signed Ranks Test, P < 0.005). Horizontal lines, group |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
medians; boxes, 25–75% quartiles, range, peak and minimum; g Real- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
time PCR analysis of Sox17 mRNA and fl-catenin expression in 31 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
matched pairs of normal and tumorous breast tissue. The ratio of the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression in tumor and normal was significant difference between |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 (gray bars) and fl-catenin (black bars) (P < 0.001, Mann– |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Whitney U test) |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
colorectal and other types of cancer, mutations of Wnt |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
pathway components were surprisingly rare in breast can- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cer [44]. However, several antagonists have been reported |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
to be frequently hypermethylated in breast cancer [29–33], |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
which indicated that epigenetic silencing of these Wnt |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
inhibitors might represent the mechanistic link between |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
active Wnt signaling and the increasing risk of breast |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer. Several lines of evidence have shown that Sox17 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
can act as an antagonist in Wnt signaling pathway [16–22]. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 can antagonize the Wnt pathway by promoting the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
degradation of fl-catenin and TCF/LEF proteins in a |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
GSK3fl-independent manner, while the reduced Sox17 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
levels have an opposite effect and could result in the hy- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
peractivation of Wnt target genes [19–21]. Thus, aberrant |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
methylation of Sox17 might contribute to activation of Wnt |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
signaling pathway in breast cancer. Our current study |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
showed that, in contrast to Sox17, the expression of fl- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
catenin was decreased after being treated with 5-aza-dC in |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer cell lines, and was significantly higher in |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumors than in paired normal tissues. Down-regulation of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 by specific siRNA silencing in two normal Sox17 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
expression cell lines SKBR-3 and Bacp37 also showed that |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
decrease of Sox17 expression could increase the expression |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
levels of fl-catenin. Therefore, our results suggest that |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 may regulate the expression of fl-catenin and loss of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 expression may be one of the reasons that lead to an |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
increase the expression of fl-catenin, which, in turn, pro- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
motes activation of Wnt signaling in breast cancer. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
In human breast cancer, other Wnt antagonists, such as |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
SFRP1 , SFRP2, SFRP5, WIF-1, and DKK-1 [29–33], have |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
been proved to be down-regulated by promoter hyperme- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
thylation. Functionally, all these antagonists act at the level |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of the cell membrane to prevent ligand–receptor interac- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tions [45]. However, different from those Wnt antagonists, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Sox17 inhibits Wnt signaling at the level of the nuclear |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
complex between fl-catenin and TCF [19–21]. Therefore, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
epigenetic silencing of Sox17 gene may result in activating |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Wnt signaling and promoting the tumor initiation and |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
progression in an independent or complementary manner |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(together with the epigenetic inactivation of other Wnt |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
inhibitors). For this reason, we could add Sox17 to the list |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of DNA hypermethylated Wnt antagonist genes in breast |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer. On the other hand, the epigenetic inactivation of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Wnt antagonist genes can be generally implicated in |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
aggressiveness features and clinical prognosis in breast |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
cancer. For example, the loss of SFRP-1 is an independent |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
indicator of poor survival [29], and epigenetic inactivation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
of the SFRP-5 gene is associated with unfavorable prog- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
nosis [31]. Meanwhile, studies have also revealed that the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
restoration of Wnt antagonist gene expression by demeth- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
ylation reagents could induce downregulation of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
downstream-activated genes of Wnt pathway and inhibit |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tumor growth rate [19, 20, 29, 31]. Thus, the specific res- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
toration of Sox17 gene expression by demethylating drugs, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
which can also affect on other Wnt antagonist genes, could |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
be applied as a new and effective therapeutic strategy to |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
improve the prognosis of breast cancer. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
In summary, our findings indicate that epigenetic sup- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
pression of Sox17 is a frequent event inhuman breast cancer. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
This frequently aberrant epigenetic event might be impor- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tant in the development and progression of breast cancer, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
and might be served as a valuable epigenetic biomarker for |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer detection, prognosis and/or treatment. Our |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
results demonstrate the biological significance and clinical |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
relevance of this gene to human breast cancer. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Acknowledgments The authors thank the studied patients for their |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
willingness to cooperate with our study. This research was supported in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
part by the grants from the National Basic Research Program of China |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
(2006CB910501, 2004CB518605), National Natural Science Founda- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tion of China (30371580, 30572109); Chinese National Natural |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
Science Fund for Distinguished Young Scholars (30625019); Shang- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
hai Science and Technology Committee (03J14019, 06DJ14004, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
06DZ19504). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
References |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
CA Cancer J Clin 57:43–66 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
2. Herman JG, Baylin SB (2003) Gene silencing in cancer in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
association with promoter hypermethylation. N Engl J Med |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
349:2042–2054. doi:10.1056/NEJMra023075 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
3. Das PM, Singal R (2007) DNA methylation and cancer. J Clin |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
Oncol 22:4632–4642. doi:10.1200/JCO.2004.07.151 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
4. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
128:683–692. doi:10.1016/j.cell.2007.01.029 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Breast Cancer Res Treat |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
5. Szyf M, Pakneshan P, Rabbani SA (2004) DNA methylation and |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
breast cancer. Biochem Pharmacol 68:1187–1197. doi:10.1016/j. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
bcp.2004.04.030 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
6. Agrawal A, Murphy RF, Agrawal DK (2007) DNA methylation |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
in breast and colorectal cancers. Mod Pathol 20:711–721. doi: |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
10.1038/modpathol.3800822 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
7. Kamachi Y, Uchikawa M, Kondoh H (2000) Pairing SOX off: |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
with partners in the regulation of embryonic development. Trends |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Genet 16:182–187. doi:10.1016/S0168-9525(99)01955-1 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
8. Wegner M (1999) From head to toes: the multiple facets of Sox |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
proteins. Nucleic Acids Res 27:1409–1420. doi: 10. 1 093/nar/27.6. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
1409 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
9. Kiefer JC (2007) Back to basics: Sox genes. Dev Dyn 236:2356– |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
2366. doi:10.1002/dvdy.21218 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
10. Lefebvre V, Dumitriu B, Penzo-Me´ndez A et al (2007) Control of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
cell fate and differentiation by Sry-related high-mobility-group |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
box (Sox) transcription factors. Int J Biochem Cell Biol 39:2195– |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
2214. doi:10.1016/j.biocel.2007.05.019 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
11. Dong C, Wilhelm D, Koopman P (2004) Sox genes and cancer. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
Cytogenet Genome Res 105:442–447. doi:10.1159/000078217 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
12. Sohn J, Natale J, Chew LJ, Belachew S et al (2006) Identification |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
of Sox17 as a transcription factor that regulates oligoden- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
drocyte development. J Neurosci 26:9722–9735. doi:10.1523/ |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
JNEUROS CI.1716-06.2006 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
13. Matsui T, Kanai-Azuma M, Hara K et al (2006) Redundant roles |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
of Sox 17 and Sox18 in postnatal angiogenesis in mice. J Cell Sci |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
119:3513–3526. doi:10.1242/jcs.03081 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
14. Park KS, Wells JM, Zorn AM et al (2006) Sox17 influences the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
differentiation of respiratory epithelial cells. Dev Biol 294:192– |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
202. doi:10.1016/j.ydbio.2006.02.038 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
15. Shimoda M, Kanai-Azuma M, Hara K et al (2007) Sox17 plays a |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
substantial role in late-stage differentiation of the extraembryonic |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
endodermin vitro. J Cell Sci 120:3859–3869. doi:10.1242/jcs.007856 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
16. Kim I, Saunders TL, Morrison SJ (2007) Sox17 dependence |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
distinguishes the transcriptional regulation of fetal from adult |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
hematopoietic stem cells. Cell 130:470–483. doi:10.1016/j.cell. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
2007.06.011 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
17. Jang YY, Sharkis SJ (2007) Fetal to adult stem cell transition: |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
knocking Sox17 off. Cell 130:403–404. doi:10.1016/j.cell.2007. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
07.027 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
18. Liu Y, Asakura M, Inoue H et al (2007) Sox17 is essential for the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
specification of cardiac mesodermin embryonic stemcells. Proc Natl |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Acad Sci USA 104:3859–3864. doi:10.1073/pnas.0609100104 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
19. Sinner D, Kordich JJ, Spence JR et al (2007) Sox17 and Sox4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
differentially regulate beta-catenin/T-cell factor activity and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
proliferation of colon carcinoma cells. Mol Cell Biol 27:7802– |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
7815. doi:10.1128/MCB.02179-06 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
20. Zhang W, Glo¨ckner SC, Guo M et al (2008) Epigenetic inacti- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
vation of the canonical Wnt antagonist SRY-box containing gene |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
17 in colorectal cancer. Cancer Res 68:2764–2772. doi: 10.1158/ |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
0008-5472.CAN-07-6349 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
21. Zorn AM, Barish GD, Williams BO et al (1999) Regulation of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
physically interact with beta-catenin. Mol Cell 4:487–498. doi: |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
10.1016/S1097-2765(00)80200-2 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
22. Kanai-Azuma M, Kanai Y, Gad JM et al (2002) Depletion of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
definitive gut endoderm in Sox17-null mutant mice. Development |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
129:2367–2379 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
23. de Jong J, Stoop H, Gillis AJ et al (2008) Differential expression of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
Sox17 and SOX2 in germ cells and stem cells has biological and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
clinical implications. J Pathol 215:21–30. doi: 10. 1002/path.2332 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
24. Morin PJ, Weeraratna AT (2003) Wnt signaling in human cancer. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
Cancer Treat Res 115:169–187. doi:10.1007/0-306-48158-8_7 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
25. Karim R, Tse G, Putti T et al (2004) The significance of the Wnt |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
pathway in the pathology of human cancers. Pathology 36:120– |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
128. doi:10.1080/00313020410001671957 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
26. Brantjes H, Barker N, van Es J et al (2002) Lady justice casting |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
the final verdict on the outcome of Wnt signalling. Biol Chem |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
383:255–261. doi:10.1515/BC.2002.027 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
27. Li Y, Welm B, Podsypanina K et al (2003) Evidence that |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
transgenes encoding components of the Wnt signaling pathway |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
preferentially induce mammary cancers from progenitor cells. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Proc Natl Acad Sci USA 100:15853–15858. doi:10.1073/pnas. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
2136825100 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
28. Howe LR, Brown AM (2004) Wnt signaling and breast cancer. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
Cancer Biol Ther 3:36–41 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
29. Veeck J, Niederacher D, An H et al (2006) Aberrant methylation |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
of the Wnt antagonist SFRP1 in breast cancer is associated with |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
unfavourable prognosis. Oncogene 25:3479–3488. doi:10.1038/ |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
sj.onc.1209386 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
30. Lo PK, Mehrotra J, D’Costa A et al (2006) Epigenetic suppres- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
sion of secreted frizzled related protein 1 (SFRP1) expression in |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
human breast cancer. Cancer Biol Ther 5:281–286 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
31. Veeck J, Geisler C, Noetzel E et al (2008) Epigenetic inactivation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
of the secreted frizzled-related protein-5 (SFRP5) gene in human |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
breast cancer is associated with unfavorable prognosis. Carcino- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
genesis 29:991–998. doi:10.1093/carcin/bgn076 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
32. Ai L, Tao Q, Zhong S et al (2006) Inactivation of Wnt inhibitory |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
factor-1 (WIF1) expression by epigenetic silencing is a common |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
event in breast cancer. Carcinogenesis 27:1341–1348. doi: |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
10.1093/carcin/bgi379 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
33. Suzuki H, Toyota M, Carraway H et al (2008) Frequent epige- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
netic inactivation of Wnt antagonist genes in breast cancer. Br J |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Cancer 98:1147–1156. doi:10.1038/sj.bjc.6604259 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
34. Akiyama H, Lyons JP, Mori-Akiyama Y et al (2004) Interactions |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
between Sox9 and beta-catenin control chondrocyte differentia- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
tion. Genes Dev 18:1072–1087. doi:10.1101/gad.1171104 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
35. Takash W, Can˜izares J, Bonneaud N et al (2001) SOX7 tran- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
scription factor: sequence, chromosomal localisation, expression, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
transactivation and interference with Wnt signalling. Nucleic |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Acids Res 29:4274–4283. doi:10.1093/nar/29.21.4274 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
36. Sinner D, Rankin S, Lee M et al (2004) Sox17 and beta-catenin |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
cooperate to regulate the transcription of endodermal genes. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Development 131:3069–3080. doi:10.1242/dev.01176 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
37. Katoh M (2002) Molecular cloning and characterization of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
human Sox17. Int J Mol Med 9:153–157 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
38. Feltus FA, Lee EK, Costello JF et al (2004) Predicting aberrant |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
CpG island methylation. Proc Natl Acad Sci USA 100:12253– |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
12258. doi:10.1073/pnas.2037852100 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
39. Ushijima T (2005) Detection and interpretation of altered meth- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
ylation patterns in cancer cells. Nat Rev Cancer 5:23–31. doi: |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
10.1038/nrc1571 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
40. Kimelman D, Xu W (2006) Beta-catenin destruction complex: |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
insights and questions from a structural perspective. Oncogene |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
25:7482–7491. doi:10.1038/sj.onc.1210055 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
41. Lin SY, Xia W, Wang JC et al (2000) Beta-catenin, a novel |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
prognostic marker for breast cancer: its roles in cyclin D1 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
expression and cancer progression. Proc Natl Acad Sci USA |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
97:4262–4266. doi:10.1073/pnas.060025397 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
42. Turashvili G, Bouchal J, Burkadze G et al (2006) Wnt signaling |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
pathway in mammary gland development and carcinogenesis. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Pathobiology 73:213–223. doi:10.1 1 5 9/00009 8 207 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
43. Dolled-Filhart M, McCabe A, Giltnane J et al (2006) Quantitative |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
in situ analysis of beta-catenin expression in breast cancer shows |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
decreased expression is associated with poor outcome. Cancer |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
Res 66:5487–5494. doi:10.1158/0008-5472.CAN-06-0100 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
44. Candidus S, Bischoff P, Becker KF et al (1996) No evidence for |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
mutations in the alpha- and beta-catenin genes in human gastric |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
and breast carcinomas. Cancer Res 56:49–52 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
45. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
signalling pathway. J Cell Sci 116:2627–2634. doi:10.1242/jcs. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
00623 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
